Mr Anthony Clare > Stephenson Harwood > London, England > Lawyer Profile
Stephenson Harwood Offices

1 FINSBURY CIRCUS
LONDON
EC2M 7SH
England
- Firm Profile
- Go to...
Mr Anthony Clare

Work Department
Corporate
Position
Anthony advises on a wide range of corporate matters including M&A (public and private), joint ventures and equity capital markets. He has acted on over 20 IPOs in the London market, with a particular bias towards issuer-side mandates. He is well known in the biotech industry and has served for over nine years on the board, and as Vice Chairman, of The Babraham Institute, Cambridge – one of Europe’s leading bioscience research institutes. Anthony is also a board trustee of the Institute of Cancer Research, one of the world’s most influential cancer research institutions.
Anthony is named as a ‘star’ in the corporate section of the 2015 edition of LMG Life Sciences and listed in the Top 50 European M&A lawyers 2014 by Global M&A Network (EMEA).
Lawyer Rankings
London > Industry focus > Life sciences and healthcare
Stephenson Harwood‘s team is skilled in addressing a range of issues for clients, including strategic collaborations, funding rounds, and life sciences M&A. The unit is led by the ‘commercially astute’ Alexandra Pygall, whose practice spans partnering agreements and IP disputes linked to partnering deals. Dan Holland has deep knowledge of clinical and commercial supply agreements. Anthony Clare is equipped to handle public and private life sciences M&A. Early-stage research, collaboration and licensing agreements are key practice strengths of Naomi Leach.
London > Corporate and commercial > M&A: Lower Mid-Market Deals, £100m-£750m
The corporate finance team at Stephenson Harwood takes a multidisciplinary approach, working alongside other practices including tax, banking and finance, and technology to advise on transactions. The group has a strong industry coverage, with particular expertise in the financial services, decarbonisation, transport and trade, technology, and healthcare sectors. It has recently seen an uptick in cross-border transactions for technology businesses. Sam Gray concentrates on cross-border M&A transactions, predominantly acting for insurance brokers and clients from the financial services sector. Duncan Stiles stands out for his extensive experience assisting US companies on European-focused acquisitions, while Ben Mercer is adept in private M&A, joint ventures, and restructuring. Life sciences and biotechnology expert Anthony Clare and corporate department head Tom Nicholls focus on public and private M&A and joint ventures- including in relation to venture capital. On the healthcare front, Karima Hudson – who rejoined the team from Taylor Wessing LLP in June 2023 – specialises in advising both operators and funders in the healthcare space. Other notable names include Jonathan Bridcut and Michelle Gomes.
Lawyer Rankings
- Life sciences and healthcare London > Industry focus
- M&A: Lower Mid-Market Deals, £100m-£750m London > Corporate and commercial
Top Tier Firm Rankings
- Private client > Art and cultural property
- Dispute resolution > Commodities disputes
- Corporate and commercial > Equity capital markets – small-mid cap
- Crime, fraud and licensing > Fraud: civil
- Investment fund formation and management > Listed funds
- Employment > Pensions: dispute resolution
- Private client > Personal tax, trusts and probate
- Transport > Rail
Firm Rankings
- Transport > Aviation
- Dispute resolution > Commercial litigation: premium
- Private client > Contentious trusts and probate
- Corporate and commercial > Financial services: contentious
- Employment > Pensions (non-contentious)
- Transport > Shipping
- Finance > Trade finance
- Finance > Transport finance and leasing
- Dispute resolution > Banking litigation: investment and retail
- Corporate and commercial > Commercial contracts
- Risk advisory > Data protection, privacy and cybersecurity
- Employment > Employers
- Dispute resolution > Group litigation: Claimant
- TMT (technology, media and telecoms) > Intellectual property: patents (contentious and non-contentious)
- TMT (technology, media and telecoms) > Intellectual property: trade marks, copyright and design
- Industry focus > Life sciences and healthcare
- Corporate and commercial > M&A: Lower Mid-Market Deals, £100m-£750m
- Corporate and commercial > Private equity: transactions - mid-market deals (up to £500m)
- Insurance > Professional negligence
- Real estate > Property litigation
- Dispute resolution > Public international law
- Risk advisory > Regulatory investigations and corporate crime (advice to corporates)
- Employment > Senior executives
- Corporate and commercial > VAT and indirect tax
- Real estate > Commercial property: investment
- Real estate > Construction: contentious
- Employment > Employee share schemes
- Crime, fraud and licensing > Fraud: white-collar crime (advice to individuals)
- Projects, energy and natural resources > Infrastructure: Project finance and development
- Insurance > Insurance and reinsurance litigation
- Dispute resolution > International arbitration
- TMT (technology, media and telecoms) > IT and telecoms
- Real estate > Property finance
- Investment fund formation and management > Real estate funds
- Projects, energy and natural resources > Renewables
- Dispute resolution > Tax litigation and investigations
- Real estate > Commercial property: development
- Real estate > Construction: non-contentious
- Finance > Corporate restructuring & insolvency
- Corporate and commercial > Corporate tax
- Insurance > Insurance: corporate and regulatory
- Projects, energy and natural resources > Oil and gas
- Projects, energy and natural resources > Power (including electricity and nuclear)
- Investment fund formation and management > Private funds
- Finance > Acquisition finance
- Public sector > Administrative and public law
- Finance > Bank lending: investment grade debt and syndicated loans
- Corporate and commercial > EU and competition
- TMT (technology, media and telecoms) > Sport